Mahmood Syed Azmal, Fariduddin Md, Banu Laila Anjuman, Hossain Shoaib, Masum Md Mohiuddin, Moyeen Samira, Selim Shahjada
Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Department of Anatomy, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Oman Med J. 2025 Jan 31;40(1):e713. doi: 10.5001/omj.2025.45. eCollection 2025 Jan.
Transcription factor 7-like 2 (TCF7L2) has emerged as a promising candidate gene associated with type 2 diabetes mellitus (T2DM), and the intronic variant rs12255372 of the gene has demonstrated a robust association with T2DM across various ethnic groups. We sought to determine the frequency of rs12255372 polymorphism in the Bangladeshi adult population, both with and without T2DM.
This cross-sectional study was conducted in the Endocrinology Department of Bangabandhu Sheikh Mujib Medical University. Eighty patients with T2DM and 80 normoglycemic controls were included in the study. The rs12255372 polymorphism was genotyped using the polymerase chain reaction-restriction fragment length polymorphism technique.
An allelic odds ratio (OR) of 3.29 (95% CI: 1.78-6.05; < 0.001) was found for the minor T allele of rs12255372, significantly increasing the T2DM risk. A significant difference in TT and GT genotypes was noted between participants with T2DM (OR = 5.26, 95% CI: 1.39-19.9; 0.008) and normoglycemic controls (OR = 3.00, 95% CI: 1.33-6.75; 0.007), respectively. The dominant model appears to be the most suitable for representing the susceptibility gene effect.
The frequency of the minor T allele of rs12255372 was about one-fourth and one-tenth among patients with T2DM and normoglycemic controls, respectively, indicating that this polymorphism may be associated with the risk of developing T2D in the studied population.
转录因子7样2(TCF7L2)已成为与2型糖尿病(T2DM)相关的一个有前景的候选基因,该基因的内含子变异rs12255372在不同种族中均显示出与T2DM有很强的关联。我们试图确定rs12255372多态性在孟加拉国成年人群(包括有和没有T2DM的人群)中的频率。
这项横断面研究在班加班杜·谢赫·穆吉布医科大学内分泌科进行。研究纳入了80例T2DM患者和80例血糖正常的对照者。使用聚合酶链反应-限制性片段长度多态性技术对rs12255372多态性进行基因分型。
发现rs12255372的次要T等位基因的等位基因优势比(OR)为3.29(95%CI:1.78 - 6.05;P < 0.001),显著增加了T2DM风险。T2DM患者(OR = 5.26,95%CI:1.39 - 19.9;P = 0.008)和血糖正常对照者(OR = 3.00,95%CI:1.33 - 6.75;P = 0.007)的TT和GT基因型之间存在显著差异。显性模型似乎最适合代表易感基因效应。
rs12255372的次要T等位基因频率在T2DM患者和血糖正常对照者中分别约为四分之一和十分之一,表明这种多态性可能与所研究人群中发生T2D的风险相关。